标题
A novel computational approach for drug repurposing using systems biology
作者
关键词
-
出版物
BIOINFORMATICS
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2018-03-09
DOI
10.1093/bioinformatics/bty133
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry
- (2017) Oliver Gautschi et al. JOURNAL OF CLINICAL ONCOLOGY
- Synergistic activity of the histone deacetylase inhibitor trichostatin A and the proteasome inhibitor PS-341 against taxane-resistant ovarian cancer cell lines
- (2017) Xin Jin et al. Oncology Letters
- Involvement of ER stress, PI3K/AKT activation, and lung fibroblast proliferation in bleomycin-induced pulmonary fibrosis
- (2017) Han-Shui Hsu et al. Scientific Reports
- IκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptor
- (2016) Sarah L. Carter et al. BMC CANCER
- Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study
- (2016) Charlotte Skriver et al. CANCER CAUSES & CONTROL
- Deoxypodophyllotoxin triggers parthanatos in glioma cells via induction of excessive ROS
- (2016) Diandong Ma et al. CANCER LETTERS
- Anticancer effects of clinically acceptable colchicine concentrations on human gastric cancer cell lines
- (2016) Zu-Yau Lin et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- New dimension of glucocorticoids in cancer treatment
- (2016) Kai-Ti Lin et al. STEROIDS
- Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF
- (2016) Paul F Mercer et al. THORAX
- Anticancer effect of deoxypodophyllotoxin induces apoptosis of human prostate cancer cells
- (2016) Sheng Hu et al. Oncology Letters
- Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma
- (2015) Dayle Rundle-Thiele et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Podophyllotoxin acetate triggers anticancer effects against non-small cell lung cancer cells by promoting cell death via cell cycle arrest, ER stress and autophagy
- (2015) JAE YEON CHOI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Efficacy of Oral Etoposide in Pretreated Metastatic Breast Cancer
- (2015) Peng Yuan et al. MEDICINE
- Colchicine Significantly Reduces Incident Cancer in Gout Male Patients
- (2015) Ming-Chun Kuo et al. MEDICINE
- Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
- (2015) Madhusoodanan Mottamal et al. MOLECULES
- Refining the treatment of NSCLC according to histological and molecular subtypes
- (2015) Anish Thomas et al. Nature Reviews Clinical Oncology
- Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells
- (2015) Sylvie Maubant et al. PLoS One
- Deoxypodophyllotoxin Isolated from Juniperus communis Induces Apoptosis in Breast Cancer Cells
- (2014) Sami Benzina et al. Anti-Cancer Agents in Medicinal Chemistry
- The role of captopril and losartan in prevention and regression of tamoxifen-induced resistance of breast cancer cell line MCF-7: An in vitro study
- (2014) Soha Namazi et al. BIOMEDICINE & PHARMACOTHERAPY
- Global Gene Repression by the Steroid Receptor Coactivator SRC-1 Promotes Oncogenesis
- (2014) C. A. Walsh et al. CANCER RESEARCH
- Chitinase 3-Like 1 Suppresses Injury and Promotes Fibroproliferative Responses in Mammalian Lung Fibrosis
- (2014) Y. Zhou et al. Science Translational Medicine
- Inhibition of Transglutaminase 2, a Novel Target for Pulmonary Fibrosis, by Two Small Electrophilic Molecules
- (2013) Keith C. Olsen et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Exposure-Response (Safety) Analysis to Identify Linifanib Dose for a Phase III Study in Patients With Hepatocellular Carcinoma
- (2013) Yi-Lin Chiu et al. CLINICAL THERAPEUTICS
- Synergistic Inhibition of Angiogenesis by Artesunate and CaptoprilIn VitroandIn Vivo
- (2013) Benjamin Krusche et al. Evidence-based Complementary and Alternative Medicine
- Interaction of Glucocorticoid Receptor (GR) with Estrogen Receptor (ER) α and Activator Protein 1 (AP1) in Dexamethasone-mediated Interference of ERα Activity
- (2013) Sudipan Karmakar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer
- (2013) Zhe Rong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Therapeutic efficacy of Sunitinib and other broad spectrum receptor tyrosine kinase inhibitors (RTKI) in bleomycin-induced pulmonary fibrosis
- (2013) D Knoerzer et al. Journal of Inflammation-London
- PI3K p110γ overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition
- (2013) Enrico Conte et al. LABORATORY INVESTIGATION
- Novel Targets in Non-Small Cell Lung Cancer: ROS1 and RET Fusions
- (2013) J. F. Gainor et al. ONCOLOGIST
- Novel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1
- (2013) MINGQIANG REN et al. ONCOLOGY REPORTS
- TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer
- (2013) Virginie Maire et al. PLoS One
- A Synthetic Podophyllotoxin Derivative Exerts Anti-Cancer Effects by Inducing Mitotic Arrest and Pro-Apoptotic ER Stress in Lung Cancer Preclinical Models
- (2013) Jia-Yang Chen et al. PLoS One
- Mefloquine induces cell death in prostate cancer cells and provides a potential novel treatment strategy in vivo
- (2013) KUN-HUANG YAN et al. Oncology Letters
- Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity
- (2013) Poornima Bhat-Nakshatri et al. Scientific Reports
- Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231
- (2013) Mariel Núñez et al. BMC Pharmacology & Toxicology
- Matrix Metalloproteinase-2 and -9 in Glioblastoma: A Trio of Old Drugs—Captopril, Disulfiram and Nelfinavir—Are Inhibitors with Potential as Adjunctive Treatments in Glioblastoma
- (2012) Richard E. Kast et al. ARCHIVES OF MEDICAL RESEARCH
- Tyrosine kinase signaling in fibrotic disorders
- (2012) Christian Beyer et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent
- (2012) Natasha Sharma et al. CANCER LETTERS
- Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast Cancer
- (2012) V. Maire et al. CANCER RESEARCH
- Suppression of cellular invasion by glybenclamide through inhibited secretion of platelet-derived growth factor in ovarian clear cell carcinoma ES-2 cells
- (2012) Tamami Yasukagawa et al. FEBS LETTERS
- Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome
- (2012) A. Chase et al. HAEMATOLOGICA
- Interplay of reactive oxygen species, intracellular Ca2+and mitochondrial homeostasis in the apoptosis of prostate cancer cells by deoxypodophyllotoxin
- (2012) Kwang-Youn Kim et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- RET Fusion Genes in Non–Small-Cell Lung Cancer
- (2012) Bo H. Chao et al. JOURNAL OF CLINICAL ONCOLOGY
- Aspirin Use and the Risk of Prostate Cancer Mortality in Men Treated With Prostatectomy or Radiotherapy
- (2012) Kevin S. Choe et al. JOURNAL OF CLINICAL ONCOLOGY
- The mTOR Pathway in Lung Cancer and Implications for Therapy and Biomarker Analysis
- (2012) Simon Ekman et al. Journal of Thoracic Oncology
- Phase 1 trial of linifanib (ABT-869) in patients with refractory or relapsed acute myeloid leukemia
- (2012) Eunice S. Wang et al. LEUKEMIA & LYMPHOMA
- Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells
- (2012) Guang Yan et al. MOLECULAR CARCINOGENESIS
- MEK-ERK Pathway Modulation Ameliorates Pulmonary Fibrosis Associated with Epidermal Growth Factor Receptor Activation
- (2011) Satish K. Madala et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Exploiting drug-disease relationships for computational drug repositioning
- (2011) J. T. Dudley et al. BRIEFINGS IN BIOINFORMATICS
- Phase II Trial of Saracatinib (AZD0530), an Oral SRC-inhibitor for the Treatment of Patients with Hormone Receptor-negative Metastatic Breast Cancer
- (2011) Ayca Gucalp et al. Clinical Breast Cancer
- Phase II Study of Sunitinib in Patients with Non-small Cell Lung Cancer and Irradiated Brain Metastases
- (2011) Silvia Novello et al. Journal of Thoracic Oncology
- Mining for therapeutic gold
- (2011) Francis S. Collins NATURE REVIEWS DRUG DISCOVERY
- Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
- (2011) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA
- (2011) G Paroni et al. ONCOGENE
- Effect of Nilotinib on Bleomycin-Induced Acute Lung Injury and Pulmonary Fibrosis in Mice
- (2011) Chin Kook Rhee et al. RESPIRATION
- Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data
- (2011) M. Sirota et al. Science Translational Medicine
- Recent developments in prostate cancer biomarker research: therapeutic implications
- (2010) Sujitra Detchokul et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Phase II Trial of Gefitinib and Everolimus in Advanced Non-small Cell Lung Cancer
- (2010) Katharine A. Price et al. Journal of Thoracic Oncology
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
- (2010) Peter M Rothwell et al. LANCET
- Targeting non-malignant disorders with tyrosine kinase inhibitors
- (2010) Friedrich Grimminger et al. NATURE REVIEWS DRUG DISCOVERY
- Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors
- (2009) J.-C. Soria et al. ANNALS OF ONCOLOGY
- A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study
- (2009) Primo N. Lara et al. ANTI-CANCER DRUGS
- Cyclin-dependent kinase inhibitor drugs as potential novel anti-inflammatory and pro-resolution agents
- (2009) AE Leitch et al. BRITISH JOURNAL OF PHARMACOLOGY
- Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862)
- (2009) Deborah Bradley et al. CANCER
- Targeting cancer with phosphodiesterase inhibitors
- (2009) Rajkumar Savai et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Histone Deacetylase Inhibitors in Cancer Therapy
- (2009) Andrew A. Lane et al. JOURNAL OF CLINICAL ONCOLOGY
- The Effect of Sirolimus on Prostate-Specific Antigen (PSA) Levels in Male Renal Transplant Recipients Without Prostate Cancer
- (2008) K. Chamie et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Glibenclamide exerts an antitumor activity through reactive oxygen species–c-jun NH(2)-terminal kinase pathway in human gastric cancer cell line MGC-803
- (2008) Xia Qian et al. BIOCHEMICAL PHARMACOLOGY
- Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy
- (2008) Bruce D Keith BMC CANCER
- Pilot Study of Rapamycin in Patients with Hormone-Refractory Prostate Cancer
- (2008) Robert J. Amato et al. Clinical Genitourinary Cancer
- The Potential Role of mTOR Inhibitors in Non-Small Cell Lung Cancer
- (2008) C. Gridelli et al. ONCOLOGIST
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now